SCOPE-DMD

SCOPE-DMD

  • Project
  • Partners
  • Patients’ Area
  • Posters, slide & logo
  • News & publications
  • Partner meetings
  • Stakeholder workshops
  • Our privacy policy

Patients’ Area

DMD is an inheritable, X-chromosome linked, lethal childhood disease with a prevalence between 0.32 and 0.52 per 10,000 inhabitants. Worldwide, around 240,000 boys suffer from DMD. DMD is caused by mutations (often deletions) in the dystrophin gene that result in the disruption of the open reading frame leading to a loss of dystrophin protein expression.

Should you have any questions regarding BioMarin trials, or Duchenne Muscular Dystrophy please contact:

Paul Humphrey – Associate Director Patient Advocacy for the EU region: Paul Humphrey

Please also visit the BioMarin website for further details: http://biomarin.com

The following website also has excellent information on DMD, current research and trials: http://www.treat-nmd.eu/

This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 601573 EU Emblem

Copyright © 2019 · Dynamik Website Builder on Genesis Framework · WordPress · Log in

This site uses cookies: Find out more.